InsiderClue
Insiders · Profile

Bonita David P

Director at Prelude Therapeutics · Director at ImageneBio · Director at Enliven Therapeutics · and 1 more. Filing since 19 Oct 2018. CIK 0001572451

PRLD Prelude Therapeutics Inc Director · 3 trades IMA ImageneBio, Inc. Director · 5 trades ELVN Enliven Therapeutics, Inc. Director · 2 trades SIBN SI-BONE, Inc. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
PRLD Prelude Therapeutics Inc
21 Apr 2026
Director
Bought
2,815,315
$12.50M
31.3%
IMA ImageneBio, Inc.
25 Jul 2025
Director
Bought
83,611
$2.50M
40.9%
PRLD Prelude Therapeutics Inc
22 May 2023
Director
Bought
869,565
$5.00M
9.4%
IMA ImageneBio, Inc.
24 Jun 2022
Director
Sold, plan not stated
162,000
$803.98K
7.5%
IMA ImageneBio, Inc.
23 Jun 2022
Director
Sold, plan not stated
23,419
$86.88K
1.2%
IMA ImageneBio, Inc.
22 Jun 2022
Director
Sold, plan not stated
66,806
$237.16K
3.4%
ELVN Enliven Therapeutics, Inc.
16 Jul 2021
Director
Bought
1,666,666
$10.00M
opened
IMA ImageneBio, Inc.
30 Mar 2021
Director
Bought
423,400
$6.77M
23.9%
PRLD Prelude Therapeutics Inc
25 Sep 2020
Director
Bought
1,236,800
$23.50M
opened
ELVN Enliven Therapeutics, Inc.
12 Mar 2020
Director
Bought
937,500
$15.00M
opened
SIBN SI-BONE, Inc.
19 Oct 2018
Director
Bought
200,000
$3.00M
25.5%
11 decisions on file.